A model for the study of the oral administration of peptide hormones.
The intragastric administration of lysine vasopressin (LVP) to rats is used as a model to study the biological activity of orally administered peptide hormones. Using a modification of the antidiuretic assay of Sawyer, LVP given by stomach tube caused a significant antidiuresis that was dose dependent in doses of 300 to 2000 mU. The simultaneous administration of the protease inhibitor, Trasylol, increased the antidiuretic effect of LVP. The synthetic peptide (1-deamino, 4 valine)-8-D-arginine-vasopressin also caused a dose-dependent prolonged and significant antidiuresis. No pressor effect was observed after intragastric administration of LVP in doses up to 40 U/rat. We are now using this model to test other procedures for enhancing the activity of lysine vasopressin administered in the gastrointestinal tract such as encapsulation into liposomes. The information gained with vasopressin will then be applied to insulin with the ultimate goal of making oral administration practical.
D000284:Administration, Oral; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001795:Blood Pressure Determination; D003894:Deamino Arginine Vasopressin / Q000031:analogs & derivatives / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D007328:Insulin / Q000008:administration & dosage; D008236:Lypressin / Q000008:administration & dosage*; D008297:Male; D008954:Models, Biological; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats
D007328:Insulin; D011480:Protease Inhibitors; D008236:Lypressin; D007611:Aprotinin; D003894:Deamino Arginine Vasopressin